ESR1 and triple-negative breast carcinoma: As illustrated in Figure 2E, the positive association between CTC enumeration and tumor metastasis remained stable across ER (positive or negative), PR (positive or negative), HER2 (positive or negative), Ki67 (<median or ≥median), and molecular subtypes (HER2 positive, luminal, or triple-negative breast cancer).